Growing prevalence of chronic and infectious diseases owing to increasing geriatric population is anticipated to stimulate demand for isothermal nucleic acid amplification technology (INAAT). Such technologies can expedite diagnostic procedures for various health disorders.
Advanced Medical Assays to Expedite Diagnostic Procedures
Major technology variants of INAAT are nucleic acid sequence based amplification (NASBA), helicase-dependent amplification (HDA), transcription-mediated amplification (TMA), loop-mediated isothermal amplification (LAMP). TMA is likely to be the dominating segment in the coming years, being the first INAAT introduced for consumers. Rising number of chronic disorders such as cancer and other infectious diseases are predicted to impel demand for such medical technologies.
Considering the rising demand, most manufacturing companies are focusing on R&D and technological advancements to offer advanced products. For instance, Hologic recently announced its third Panther Fusion assay that got clearance from food and drug administration (FDA). This new assay can detect rhinovirus, adenovirus, and human metapneumovirus. Other two assays under panther fusion system are Panther Fusion Paraflu assay and panther fusion flu A/B/RSV assay. All three assays are expected to deliver modular approach to syndromic respiratory tests.
Market Insights
The worldwide isothermal nucleic acid amplification technology market is predicted to reach USD 4.3 billion by 2025, according to a report by Grand View Research, Inc. Rising number of geriatric population and growing necessity of INAAT over traditional diagnostic techniques can stimulate growth of the market. Growing adoption of molecular diagnostics owing to increase in disposable income can drive growth of the market. Increasing number of chronic infections such as respiratory viral infections, diarrhea, and pneumonia are predicted to fuel market growth. Rise in miniaturization of nucleic acid-based diagnostic procedures can impel demand for isothermal nucleic acid amplification technology market. Growing necessity for rapid, disease-specific, and user-friendly kits to stimulate diagnosis for various infections can exhilarate market growth during the forecast period (2017 to 2025).
Some of the prominent players operating in the market for INAAT are QIAGEN, Dickinson & Company, Quidel Corporation, ThermoFisher Scientific, and Becton.
In-Depth Research Report On Isothermal Nucleic Acid Amplification Technology (INAAT) Market:
https://www.grandviewresearch.com/industry-analysis/isothermal-nucleic-acid-amplification-technology-inaat-market
No comments:
Post a Comment